Cargando…

Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys

IMPORTANCE: Estimates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease burden are needed to help guide interventions. OBJECTIVE: To estimate the number of SARS-CoV-2 infections, symptomatic infections, hospitalizations, and deaths in the US as of November 15, 2020. DESIGN, SET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angulo, Frederick J., Finelli, Lyn, Swerdlow, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786245/ https://www.ncbi.nlm.nih.gov/pubmed/33399860 http://dx.doi.org/10.1001/jamanetworkopen.2020.33706

Ejemplares similares

Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020
por: Finelli, Lyn, et al.
Publicado: (2021)

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
por: Bajema, Kristina L., et al.
Publicado: (2020)

Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic
por: Anand, Shuchi, et al.
Publicado: (2021)

Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection
por: Ioannou, George N., et al.
Publicado: (2020)

The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths
por: Yamana, Teresa K., et al.
Publicado: (2023)

Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster
por: McConeghy, Kevin W., et al.
Publicado: (2022)

Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves
por: Boon, Siaw S., et al.
Publicado: (2021)

Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia
por: Rogawski McQuade, Elizabeth T., et al.
Publicado: (2021)

Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021
por: Steele, Molly K., et al.
Publicado: (2022)

Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
por: El-Ghitany, Engy Mohamed, et al.
Publicado: (2022)

Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009
por: Reed, Carrie, et al.
Publicado: (2009)

Systematic literature review of SARS-CoV-2 seroprevalence surveys in Canada through April 2021
por: Major, Maria, et al.
Publicado: (2022)

Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022
por: Hatfield, Kelly M., et al.
Publicado: (2023)

Estimated Projection of US Cancer Incidence and Death to 2040
por: Rahib, Lola, et al.
Publicado: (2021)

Risk Factors Associated With SARS-CoV-2 Infections, Hospitalization, and Mortality Among US Nursing Home Residents
por: Mehta, Hemalkumar B., et al.
Publicado: (2021)

State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020
por: Cardenas, Victor M., et al.
Publicado: (2022)

Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy
por: Poletti, Piero, et al.
Publicado: (2021)

Development of COVIDVax Model to Estimate the Risk of SARS-CoV-2–Related Death Among 7.6 Million US Veterans for Use in Vaccination Prioritization
por: Ioannou, George N., et al.
Publicado: (2021)

Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
por: Payne, Amanda B., et al.
Publicado: (2021)

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
por: Buchan, Sarah A., et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection – A multistage national household survey and modelling study, Dominican Republic, June–October 2021
por: Nilles, Eric J., et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021
por: Wang, William, et al.
Publicado: (2022)

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection in an Italian cohort in Marche Region, Italy
por: De Santi, Mauro, et al.
Publicado: (2021)

Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S.
por: García-Carreras, Bernardo, et al.
Publicado: (2023)

Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua
por: Kubale, John, et al.
Publicado: (2022)

Self-administered, remote assessment of SARS-CoV-2 seroprevalence in health care workers
por: Card, Lauren, et al.
Publicado: (2022)

SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria
por: Kolawole, Olatunji Matthew, et al.
Publicado: (2022)

Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022
por: Briggs, Jessica, et al.
Publicado: (2023)

Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemic
por: Lozano-Sanchez, Fernando, et al.
Publicado: (2021)

Estimation of Potential Deaths Averted From Hypothetical US Income Support Policies
por: Avanceña, Anton L. V., et al.
Publicado: (2022)

Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys
por: Irons, Nicholas J., et al.
Publicado: (2021)

Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative
por: Bennett, Tellen D., et al.
Publicado: (2021)

Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
por: Larremore, Daniel B, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline
por: Bolotin, Shelly, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada
por: Zinszer, Kate, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence among healthcare personnel at a large health system in Atlanta
por: Graciaa, Daniel S., et al.
Publicado: (2022)

Using Routine Surveillance Data to Estimate the Epidemic Potential of Emerging Zoonoses: Application to the Emergence of US Swine Origin Influenza A H3N2v Virus
por: Cauchemez, Simon, et al.
Publicado: (2013)

Serological survey to estimate SARS-CoV-2 infection and antibody seroprevalence at a large public university: A cross-sectional study
por: Hou, Ching-Wen, et al.
Publicado: (2023)

SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer
por: Hosseini-Moghaddam, Seyed M., et al.
Publicado: (2023)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ua7uvob3b9ihhk6om50frnlo1